G75S (p.Gly75Ser) variant of KRT17 (Keratin, type I cytoskeletal 17)

G75S (p.Gly75Ser) in KRT17 (Keratin, type I cytoskeletal 17) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes population frequency data and structural context.

G75S (p.Gly75Ser) variant details